Seroatlas · Human Serome Atlas

EIF1

Eukaryotic translation initiation factor 1

Also known as: A121, EIF-1, EIF1_HUMAN, EIF1A, ISO1, SUI1

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P41567
Gene
EIF1
Ensembl
ENSG00000173812
Chromosome
17
Canonical length
113 aa
Protein class
Plasma proteins, Predicted intracellular proteins

OverviewNCBI Gene

Enables ribosomal small subunit binding activity and translation initiation factor activity. Involved in regulation of translational initiation and translational initiation. Located in cytoplasm and nucleus. Part of eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; and multi-eIF complex. [provided by Alliance of Genome Resources, Jul 2025]

Canonical amino-acid sequenceUniProt

113 residues, UniProt reviewed canonical sequence.

>P41567|EIF1
     1  MSAIQNLHSF DPFADASKGD DLLPAGTEDY IHIRIQQRNG RKTLTTVQGI ADDYDKKKLV
    61  KAFKKKFACN GTVIEHPEYG EVIQLQGDQR KNICQFLVEI GLAKDDQLKV HGF

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against EIF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.42
Highest tissue expression
1,182 nTPM

Expression across tissuesHPA

Tissue

  • skeletal muscle: 1,182 nTPM
  • bone marrow: 712 nTPM
  • blood vessel: 466 nTPM
  • heart muscle: 463 nTPM
  • adipose tissue: 459 nTPM
  • pancreas: 456 nTPM

Single-cell type

  • esophageal apical cells: 15,382 nCPM
  • late spermatids: 10,962 nCPM
  • syncytiotrophoblasts: 5,022 nCPM
  • esophageal suprabasal cells: 4,944 nCPM
  • pancreatic acinar cells: 4,157 nCPM
  • decidual stromal cells: 3,771 nCPM

Immune cell

  • basophil: 1,148 nTPM
  • total PBMC: 592 nTPM
  • eosinophil: 465 nTPM
  • non-classical monocyte: 458 nTPM
  • intermediate monocyte: 440 nTPM
  • T-reg: 430 nTPM

Brain region

  • white matter: 481 nTPM
  • medulla oblongata: 443 nTPM
  • cerebellum: 423 nTPM
  • basal ganglia: 415 nTPM
  • pons: 413 nTPM
  • hypothalamus: 404 nTPM

ReferencesPubMed · IEDB

Publications for EIF1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.51
gnomAD pLI
0.83
gnomAD missense Z
1.87
DepMap mean gene effect
-1.14
DepMap dependency class
common

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of EIF1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads EIF1 as an antibody target. Whether an autoantibody or antibody against EIF1 could matter depends on whether native EIF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

EIF1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label EIF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/EIF1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...